Fletikumab

Fletikumab (NNC0109-0012) (INN^[1]) is a monoclonal antibody designed for the treatment of rheumatoid arthritis^[2] that targets IL-20.^[3]

Fletikumab

Monoclonal antibody
Type	?
Target	IL20
Clinical data
Other names	NNC0109-0012
ATC code	none
Identifiers
CAS Number	1357158-22-5
ChemSpider	none
UNII	82WG3POL9W
KEGG	D11756
ChEMBL	ChEMBL3301580
Chemical and physical data
Formula	C6494H10000N1728O2050S44
Molar mass	146492.12 g·mol−1

This drug was being developed by Novo Nordisk A/S until Novo ceased work in inflammation.